ORMPNasdaq Israel
Market cap
$178.869 M
$4.30 +0.00%
Close of 7 Aug 2026
Revenue
$2.00M
#3439 by revenue
Earnings
$75.3K
#2460 by earnings
Shares outstanding
40,926,081
Latest filing cover page
P/E ratio
2374.7
Cap ÷ net income
Where these numbers come from
Share counts and financials for Oramed Pharmaceuticals are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.